Nano-X Imaging

Nano-X Imaging Ltd. is engaged in the development of medical imaging systems. Its product Nanox System consists of hardware Nanox.ARC and software Nanox.CLOUD that provides image repository, radiologist matching, online and offline diagnostics review and annotation, connectivity to diagnostic assistive artificial intelligence systems, billing, and reporting. The firm operates through the following segments: Nanox.Arc, AI Solutions, and Radiology Services. The company was founded by Ran Poliakine and Hitoshi Masuya in 2011 and is headquartered in Neve Ilan, Israel.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Nano-X Imaging reports progress in regulatory clearances and strategic partnerships

Nano-X Imaging showcased progress in regulatory clearances, commercialization efforts, strategic partnerships, and operational optimization during the Q4 2022 Earnings Call.
Despite challenges in regulatory compliance, expenses management, and market competition, the company's strengths in innovation, partnerships, and financial resilience position it well for future growth.
Opportunities for Nano-X Imaging include global expansion, technological advancements, cost efficiencies, and leveraging market demand for imaging solutions.
Overall, Nano-X Imaging's performance in Q4 2022 reflects a strategic focus on growth, innovation, and market expansion in the medical imaging industry.

Nano-X Imaging reports improved Q1 performance and expands global reach

Nano-X Imaging's Q1 2023 performance showed improvement with a reported net loss of $11.8 million and revenue of $2.4 million. The company is focusing on deploying Nanox.ARC globally, strengthening manufacturing capabilities, and expanding market reach through strategic partnerships. Challenges include managing expenses and driving revenue growth to achieve profitability.

Nanox Imaging reports Q2 results, eyes U.S. market growth

Nanox Imaging's Q2 2023 performance reflects investment in growth initiatives, with a focus on market expansion and product deployment.
The company faces financial challenges, including a significant net loss and accrued expenses related to an SEC investigation, necessitating prudent financial management.
Strategic strengths in the U.S. market entry, global commercialization efforts, and strong cash position position Nanox Imaging for future growth and market success.
Opportunities lie in upcoming Investor Day, FDA clearance for Nanox.ARC, and expansion in Africa, offering avenues for revenue growth and market leadership.

Nanox Imaging reports Q3 revenue growth and strategic advancements

Nanox Imaging's Q3 2023 performance showed revenue growth and strategic advancements. While facing financial challenges and potential execution hurdles, the company's focus on expansion and partnerships positions it for future growth.

Nanox Imaging reports Q4 loss, eyes global expansion and AI

Nanox Imaging's Q4 2023 performance showed a mix of revenue growth and strategic investments in technology and market expansion.
The company's strengths lie in its progress with regulatory clearances, commercialization efforts, and success in AI applications.
Challenges include slow AI adoption, implementation hurdles, and the need to overcome barriers to data sharing and transparency.
Opportunities exist in expanding HealthCCS usage, global market presence, and addressing AI adoption challenges for revenue growth.

Nanox Imaging reports Q1 loss, eyes global expansion and AI growth

Nanox Imaging's Q1 2024 performance reflects revenue generation from AI solutions and system sales amid challenges in gross profit margins and a notable net loss.
The company's strategic strengths in partnerships, product launches, and global expansions position it well for future growth and market competitiveness.
While facing challenges in cost management and profitability, Nanox Imaging holds opportunities in expanded indications, market expansions, and AI solutions deployment.

Nano-X Imaging reports Q2 losses, eyes growth through FDA clearances

Nano-X Imaging (NNOX) showcased progress in commercial and clinical fronts but faces challenges in narrowing losses and optimizing operations.
Strategic collaborations, FDA clearances, and global deployment offer opportunities for growth and market expansion.
The focus on transformative imaging solutions and commercial infrastructure acceleration underlines NNOX's commitment to innovation and market leadership.

Nanox Imaging reports mixed Q3 results amidst growth opportunities

Nanox Imaging reported mixed financial results with revenue of $3.0 million and a gross loss of $2.8 million, while achieving record revenue from USARAD business.
The company showcased strengths in technology deployment, partnerships, and clinical trials, but faces challenges in regulatory clearances and financial performance.
Opportunities exist in market expansion, revenue growth, and operational efficiency improvements to drive future success and profitability.
With a strong focus on innovation, partnerships, and market expansion, Nanox is poised for growth but needs to address regulatory hurdles and financial performance.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Nano-X Imaging Ltd. is engaged in the development of medical imaging systems. Its product Nanox System consists of hardware Nanox.ARC and software Nanox.CLOUD that provides image repository, radiologist matching, online and offline diagnostics review and annotation, connectivity to diagnostic assistive artificial intelligence systems, billing, and reporting. The firm operates through the following segments: Nanox.Arc, AI Solutions, and Radiology Services. The company was founded by Ran Poliakine and Hitoshi Masuya in 2011 and is headquartered in Petach Tikva, Israel.

San Francisco, California--(Newsfile Corp. - September 20, 2020) - Hagens Berman urges Nano-X Imaging Ltd.

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Nano-X Imaging (NNOX) Investors with Significant Losses to Contact Its Attorneys, Securities Fraud Case Filed

Ontrak

Zymeworks Inc

The opportunity is vast for Ontrak, Nano-X Imaging, and Zymeworks.

3 Top Biotech Picks for 2025

NEW YORK, Sept. 19, 2020 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of Nano-X Imaging Ltd. (NASDAQ: NNOX), between August 21, 2020 and September 15, 2020, inclusive (the "Class...

ROSEN, A GLOBALLY RECOGNIZED FIRM, First Files Securities Class Action Lawsuit Against Nano-X Imaging Ltd. - NNOX

NEW YORK, Sept. 18, 2020 /PRNewswire/ -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Nano-X Imaging Ltd. ("Nano-X" or the "Company") (NASDAQ: NNOX). A complaint has been filed on behalf of investors who purchased the publicly traded...

Investor Alert: Kaplan Fox Investigates Nano-X Imaging For Potential Securities Fraud

NEW YORK--(BUSINESS WIRE)---- $NNOX #classaction--The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Eastern District of New York on behalf of those who acquired Nano-X Imaging Ltd.

INVESTOR ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action Lawsuit Against Nano-X Imaging Ltd.

NEVE ILAN, Israel and TAIPEI, Taiwan, Sept.  18, 2020  (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (NASDAQ: NNOX) (“Nanox” or the “Company”), an innovative medical imaging technology company, announced today that Ran Poliakine, Chairman and Chief Executive Officer, will be participating in the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit, which is being held virtually from September 21-23, 2020.

Nanox to Participate in the Oppenheimer’s Virtual Fall Healthcare Life Sciences & MedTech Summit

NEW YORK--(BUSINESS WIRE)--Bernstein Liebhard, a nationally acclaimed investor rights law firm, announces that a securities class action has been filed on behalf of investors that purchased or acquired the securities of Nano-X Imaging Ltd. (“Nano-X” or the “Company”) (NASDAQ: NNOX) between August 21, 2020 and September 15, 2020 (the “Class Period”).

NNOX SHAREHOLDER ALERT: Bernstein Liebhard Announces that a Securities Class Action Lawsuit has Been Filed Against Nano-X Imaging Ltd.

NEW YORK, Sept. 18, 2020 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Nano-X Imaging Ltd. ("Nano-X" or "the Company") (NASDAQ: NNOX) and certain of its officers, on behalf of shareholders...

NNOX Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Nano-X Imaging Ltd. Investors of Class Action and Encourages Shareholders to Contact the Firm

PHILADELPHIA, Sept. 17, 2020 /PRNewswire/ -- Kaskela Law LLC announces that a shareholder class action lawsuit has been filed against Nano-X Imaging Ltd. ("Nano-X" or the "Company") (NASDAQ: NNOX) on behalf of investors who purchased Nano-X's securities between August 21, 2020 and...

Kaskela Law LLC Announces Shareholder Class Action Lawsuit Against Nano-X Imaging Ltd. (NNOX) and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

LOS ANGELES--(BUSINESS WIRE)---- $NNOX #NNOX--SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Nano-X Imaging Ltd.

SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Nano-X Imaging Ltd. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Two analysts now consider Nano-X to be just "Theranos 2.0."

Why Nano-X Imaging Stock Just Crashed Another 14%

New York, New York--(Newsfile Corp. - September 17, 2020) - Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of Nano-X Imaging Ltd.

ROSEN, A TOP RANKED FIRM, Files First Securities Class Action Lawsuit Against Nano-X Imaging Ltd. - NNOX

LOS ANGELES--(BUSINESS WIRE)---- $NNOX #classaction--The Law Offices of Frank R. Cruz announces an investigation of Nano-X Imaging Ltd.

 The Law Offices of Frank R. Cruz Announces Investigation of Nano-X Imaging Ltd.

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of Nano-X Imaging Ltd. (NASDAQ: NNOX), between August 21, 2020 and September 15, 2020, inclusive (the “Class Period”).

EQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit Against Nano-X Imaging Ltd. – NNOX

LOS ANGELES--(BUSINESS WIRE)---- $NNOX #NNOX--INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Nano-X Imaging Ltd.

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Nano-X Imaging Ltd. and Encourages Investors with Losses of $100,000 to Contact the Firm

The stock yo-yos as investors struggle to decide whom to believe.

Why Nano-X Stock Dropped 9%, Bounced Back 25%, and Is Still Up 5.5% Today

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of Nano-X Imaging Ltd. (NASDAQ: NNOX) resulting from allegations that Nano-X may have issued materially misleading business information to the investing public.

EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Nano-X Imaging Ltd. – NNOX

NEVE ILAN, Israel, Sept.  16, 2020  (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (NASDAQ: NNOX) (“Nanox” or the “Company”), an innovative medical imaging technology company, today issued a statement in response to unusual trading activities that occurred on September 15, 2020.

Nanox Issues Statement on Unusual Trading Activities

Shares of the affordable imaging gear maker have more than tripled since its IPO in August.

Is It Already Too Late to Buy Nano-X Stock?

SAN FRANCISCO, Sept. 15, 2020 /PRNewswire/ -- Hagens Berman urges Nano-X Imaging Ltd.

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Investigating Possible Securities Law Violations by Nano-X Imaging (NNOX), Encourages NNOX Investors and Whistleblowers to Contact the Firm

Why Nano-X Stock Just Crashed 28%

SAN DIEGO, Sept. 15, 2020 /PRNewswire/ -- Shareholder rights law firm Johnson Fistel, LLP is investigating potential violations of the federal securities laws by Nano-X Imaging Ltd.

Nano-X (NNOX) Alert: Johnson Fistel Investigates Nano-X Imaging Ltd.; Investors Suffering Losses Encouraged to Contact Firm

Why Nano-X Imaging Stock Just Crashed 15%

NEVE ILAN, Israel and TAIPEI, Taiwan, Sept.  10, 2020  (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (NASDAQ: NNOX) (“Nanox” or the “Company”), an innovative medical imaging technology company, announced today that Ran Poliakine, Chairman and Chief Executive Officer and other members of the leadership team will be participating in two upcoming investor conferences.

Nanox to Participate in Two Upcoming Investor Conferences

Nano-X secures multiyear, multimillion-dollar deal in Mexico.

News for Nano-X Imaging Stock (NNOX)